Pentoxifylline

Applications

NDAs, BLAs and generic ANDAs for this ingredient, oldest first; each opens its full history

Approved	Application	Sponsor	Supplements	Marketing
Aug 30, 1984	TrentalNDA 18631 · New molecular entity	Validus Pharms	32	Marketed
Jul 8, 1997	PentoxifyllineANDA 74425	Rising	16	Marketed
Jul 8, 1997	PentoxifyllineANDA 74877	Heritage	5	Discontinued
Jul 9, 1997	PentoxifyllineANDA 74878	Ani Pharms	10	Marketed
Jul 20, 1998	PentoxifyllineANDA 75028	Bausch	10	Discontinued
Sep 4, 1998	PentoxifyllineANDA 75107	Ani Pharms	4	Discontinued
Mar 31, 1999	PentoxilANDA 74962	Upsher Smith Labs	5	Discontinued
May 25, 1999	PentoxifyllineANDA 74874	Pliva	8	Discontinued
Jun 9, 1999	PentoxifyllineANDA 75191	Apotex	11	Marketed
Aug 10, 1999	PentoxifyllineANDA 75093	Impax Labs	2	Discontinued
Sep 3, 1999	PentoxifyllineANDA 75199	Ani Pharms	1	Discontinued

Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA